PharmiWeb.com - Global Pharma News & Resources

Marketing - Press Releases

Date Title Company
29-May-2020 Chi-Med Announces NDA Acceptance in China for Savolitinib in the Treatment of Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutations Chi-Med
29-May-2020 Interim analysis presented at the American Society of Clinical Oncology (ASCO) Annual Meeting London’s Global University
28-May-2020 Peli BioThermal Expands Global Rental Network in Incheon, South Korea Peli BioThermal
28-May-2020 Sanofi intends to sell its equity investment in Regeneron; confirms no change to ongoing collaboration Sanofi
28-May-2020 Gavi: Partnering to protect future generations from infectious diseases ABPI
28-May-2020 Sareum to Present at BIO Digital 2020 Sareum
28-May-2020 Oxitec’s New Friendly Aedes aegypti Mosquito Technology Receives Full Biosafety Approval in Brazil Oxitec
28-May-2020 Laboratory relocation specialist backs NHS tribute Aport
28-May-2020 Sanofi announces pricing of Regeneron stock offering Sanofi
28-May-2020 Shinshu University and Toshiba Develop Tumor-Tropic Liposome Technology that Carries Therapeutic Genes into Cancer Cells Toshiba Corporation
28-May-2020 (Covid-19) Impact Analysis : Media Relation Service Market Size, Trends, Analysis, Demand, Outlook and Forecast to 2024 Qurate Business Intelligence
21-May-2020 Santhera Completes Enrollment of Phase 3 SIDEROS Study with Puldysa® (Idebenone) in Duchenne Muscular Dystrophy (DMD) Santhera Pharmaceuticals
20-May-2020 Oxford Biomedica receives MHRA approval for the first two manufacturing suites in Oxbox Oxford Biomedica
20-May-2020 Europlaz Technologies Ltd secures contract to manufacture COVID-19 Test Kits Europlaz Technologies Ltd
20-May-2020 BARDA Provides the Sabin Vaccine Institute with an Additional $20 Million for Further Development of Ebola Sudan and Marburg Vaccines The Sabin Vaccine Institute (Sabin)
20-May-2020 Ori Biotech and CellGenix to collaborate in order to promote innovation within closed-system cell and gene therapy manufacturing Ori Biotech
20-May-2020 Why research on ticks could offer potential COVID-19 breakthrough ILC Therapeutics
20-May-2020 European Commission Approves Subcutaneous Formulation of Entyvio® (Vedolizumab) for use as Maintenance Therapy in Adults with Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease Takeda Pharmaceutical Company Limited
20-May-2020 Breakthrough Innovation in Cancer Care From Merck Pipeline to Be Presented at ASCO 2020 Merck
20-May-2020 Nivolumab plus ipilimumab with chemotherapy shows improved overall survival vs. chemotherapy alone in first-line metastatic nonsmall cell lung cancer in a phase 3 trial Bristol Myers Squibb